LCH Portal Account Management Please use below links to raise a registration (including Knowledge Centre access) /activation request.
Secure login portal for LCH Group customers and partners requiring prior authorization for access.
This section of the LCH website is to keep members updated with plans and progress. Please be aware that access to the Secure Area is limited to authorised users and that LCH reserves the discretion to grant or refuse access.
LCH.Clearnet is the leading European equity central counterparty, providing clearing services to clients for equities, and equity equivalents such as exchange traded funds (ETFs), exchange traded commodities (ETCs) real estate investment trusts (REITS) and exchange traded bonds.
For LCH LTD, LCH SA and SMART Support, please login here to create a case. Alternatively, if you are unable to login and still wish to raise a support ticket for any LCH services or environments, please use this webform.
Langerhans' Cell Histiocytosis (LCH) is a serious type of cancer-like disease that mainly affects children and can be fatal in severe cases. About five to ten children get the disease in Sweden every ...
Mixed histiocytosis (Langerhans cell histiocytosis [LCH] / Erdheim-Chester disease [ECD]) developing after treatment for initial skull LCH is not well recognized.
LCH.Clearnet has outlined its suggestions for a stress-testing framework for central counterparties (CCPs), identifying three key principles for the tests: transparency, simplicity and comparability.
The findings presented in Science Immunology may lead to new, targeted treatments. Langerhans’ Cell Histiocytosis (LCH) is a serious type of cancer-like disease that mainly affects children and can be ...